3 companies
D'Ieteren Group
Market Cap: €9.0b
Operates as an investment company in Belgium, France, rest of Europe, and internationally.
DIE
€168.90
7D
-2.0%
1Y
-6.6%
argenx
Market Cap: €44.5b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€718.00
7D
1.7%
1Y
42.0%
UCB
Market Cap: €47.9b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€254.20
7D
3.9%
1Y
56.9%